Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06983470 · ClinicalTrials.gov registry record · NA
Predictive Utility and Mechanisms of Sacral Evoked Responses in Sacral Neuromodulation
A NA study of Overactive Bladder, sponsored by University of Michigan.
- Recruiting
- Registry status
- NA
- Development phase
- 15
- Enrollment target
- 1
- Study location
NCT06983470: Recruiting NA study of Overactive Bladder, sponsored by University of Michigan.
NCT06983470 is a NA study of Overactive Bladder that is actively recruiting participants, run by University of Michigan. The registered enrollment target is 15 participants, below the 207-participant average among 46 other Overactive Bladder trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06983470, a NA study of Overactive Bladder, is actively recruiting participants, sponsored by University of Michigan.
- RECRUITING
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
- 1
- Study location
Study Summary
Electrical stimulation of the sacral nerve can help with bladder problems and pelvic pain but researchers don't understand exactly how the stimulation helps. The goal of this study is to examine signals evoked during sacral neuromodulation (SNM or electrical stimulation of the sacral nerve) and their relationship to the selection of stimulation parameters that improve pelvic function symptoms. This study uses SNM parameters based on visual-motor responses (VMR) or sacral evoked responses (SER). It is investigating how the parameter selection impacts change in bladder function.
Primary Outcome
Bladder function score is assessed using the American Urological Association Symptom Index. The American Urological Association Symptom Index has a range of 0 (no dysfunction) to 35 (maximum dysfunction). A decrease in score indicates improvement.
Conditions Studied
Interventions
- DEVICE SNM based on visual-motor responses (VMRs)
- DEVICE SNM based on sacral evoked responses (SERs)
Study Locations (1)
Michigan
- University of Michigan - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2025-10-16 |
| Est. Completion | 2029-10 |
| Phase | NA |
What NCT06983470 shows while recruiting
NCT06983470 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 207-participant average among 46 other Overactive Bladder trials with a reported enrollment target (93% lower).
The record links to 1 condition, with Overactive Bladder appearing as the primary indexed condition, and to 2 interventions - of which SNM based on visual-motor responses (VMRs) is the first listed.
NCT06983470 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT06983470 about?
NCT06983470 is a clinical study titled "Predictive Utility and Mechanisms of Sacral Evoked Responses in Sacral Neuromodulation". Electrical stimulation of the sacral nerve can help with bladder problems and pelvic pain but researchers don't understand exactly how the stimulation helps. The goal of this study is to examine signals evoked during sacral neuromodulation (SNM or electrical stimulation of the sacral nerve) and thei...
What is the current status of trial NCT06983470?
This trial is currently recruiting. It is a NA study. The enrollment target is 15 participants. The study started on 2025-10-16. Estimated completion is 2029-10.
What conditions does trial NCT06983470 study?
This clinical trial studies the following conditions: Overactive Bladder.
What interventions are being tested in trial NCT06983470?
The interventions under investigation include: SNM based on visual-motor responses (VMRs) (DEVICE), SNM based on sacral evoked responses (SERs) (DEVICE).
Who is sponsoring clinical trial NCT06983470?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06983470 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Overactive Bladder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06983470's enrollment target sits among peer trials
15 44th of 46 higher than 3 of 46 other Overactive Bladder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Overactive Bladder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Home Versus Office Removal of Percutaneous Nerve Evaluation (PNE) Lead
RECRUITING · NA
-
Percutaneous Nerve Evaluation Trial Time
RECRUITING · NA
-
Sacral Neuromodulation for Male Overactive Bladder (MOAB)
RECRUITING · NA
-
Neuromodulating Cortical Regions Involved in Neurogenic Bladder in MS
RECRUITING · NA
-
A Real World Study of eCoin for Urgency Urinary Incontinence: Post Approval Evaluation (RECIPE)
RECRUITING · NA
-
At-Home Transcutaneous Tibial Nerve Stimulation for Overactive Bladder in Rural Women
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI